Spectrum Pharmaceuticals, Inc. An International Commercial-Stage Biotechnology Company
Spectrum Pharmaceuticals, Inc. An International Commercial-Stage Biotechnology Company
Home > Product Portfolio > Out-Licensing

Out-Licensing OpportunitiesSpectrum Pharmaceuticals, Inc. An International Commercial-Stage Biotechnology Company

Many of our drug candidates are available for out-licensing in regions outside the U.S., such as Europe and Asia. The following is a list of our proprietary drugs available for co-development:

 

In addition, Spectrum has a portfolio of neurology drug candidates that are available for out-licensing.

For more information regarding these compounds and all our various out-licensing options, please contact us.